The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

This publication has 24 references indexed in Scilit:

• Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell Transplantation
  Transplantation and Cellular Therapy, 2009
• Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective
  Bone Marrow Transplantation, 2009
• Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits
  Nature, 2008
• Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients
  Bone Marrow Transplantation, 2007
• Vancomycin‐resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high‐risk
  European Journal of Haematology, 2007
• Nosocomial Spread of Linezolid-Resistant, Vancomycin-ResistantEnterococcus faecium
  New England Journal of Medicine, 2002
• High Rate of False‐Negative Results of the Rectal Swab Culture Method in Detection of Gastrointestinal Colonization with Vancomycin‐Resistant Enterococci
  Clinical Infectious Diseases, 2002
• The Effect of Vancomycin and Third-Generation Cephalosporins on Prevalence of Vancomycin-Resistant Enterococci in 126 U.S. Adult Intensive Care Units
  Annals of Internal Medicine, 2001
• Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid
  The Lancet, 2001
• Incidence and outcome of vancomycin-resistant enterococcal bacteremia following autologous peripheral blood stem cell transplantation
  Bone Marrow Transplantation, 2000